Suzuki, H I
Katsura, A
Matsuyama, H
Miyazono, K
Article History
Received: 4 May 2014
Revised: 4 June 2014
Accepted: 6 June 2014
First Online: 18 August 2014
Competing interests
: Works by Dr Suzuki and Dr Miyazono have been funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. Dr Suzuki is also supported by a fund from the Cell Science Research Foundation. Dr Miyazono has received compensation as a member of the scientific advisory board of Isarna Therapeutics GmbH. He also owns stock in Immunofuture, Inc. Mr Matsuyama is currently an employee of the Otsuka Maryland Medicinal Laboratories, Inc. Dr Katsura declares no potential conflict of interest.